Biotech by today's price change
How far the share price has moved since the previous close.
CRISPR Therapeutics leads the 24 biotech ranked by today's price change, at +4.74%, ahead of Scholar Rock Holding (+4.40%) and Repligen (+4.23%). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- CRISPR Therapeutics+4.74%
- Median
- +0.19%
- Combined market value
- CZK 18.78T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | +4.74% | CZK 90.5B | CZK 933.45 | 4.74% up | 21% down | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | +4.40% | CZK 127.4B | CZK 1,044.59 | 4.40% up | 14% up | ||
| 3 | RepligenRGEN · Health Care | +4.23% | CZK 239.8B | CZK 3,752.01 | 4.23% up | 5% up | ||
| 4 | Krystal BiotechKRYS · Health Care | +1.18% | CZK 198.7B | CZK 6,704.97 | 1.18% up | 46% up | ||
| 5 | argenxARGX · Health Care | +1.15% | CZK 1.34T | CZK 21,272.65 | 1.15% up | 4% up | ||
| 6 | ImmunovantIMVT · Health Care | +1.05% | CZK 154.2B | CZK 744.90 | 1.05% up | 43% up | ||
| 7 | CG OncologyCGON · Health Care | +0.98% | CZK 158B | CZK 1,769.33 | 0.98% up | 85% up | ||
| 8 | Kodiak SciencesKOD · Health Care | +0.60% | CZK 141.3B | CZK 2,161.45 | 0.60% up | 396% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | +0.53% | CZK 231.5B | CZK 2,711.69 | 0.53% up | 87% up | ||
| 10 | ExelixisEXEL · Health Care | +0.49% | CZK 372.8B | CZK 1,527.86 | 0.49% up | 63% up | ||
| 11 | Adaptive BiotechnologiesADPT · Health Care | +0.32% | CZK 102.7B | CZK 634.36 | 0.32% up | 88% up | ||
| 12 | BiogenBIIB · Health Care | +0.25% | CZK 824.9B | CZK 5,580.52 | 0.25% up | 49% up | ||
| 13 | Bio-TechneTECH · Health Care | +0.12% | CZK 253.6B | CZK 1,614.09 | 0.12% up | 26% up | ||
| 14 | BioNTechBNTX · Health Care | +0.02% | CZK 467.1B | CZK 1,884.00 | 0.02% up | 16% down | ||
| 15 | Halozyme TherapeuticsHALO · Health Care | +0.01% | CZK 242.9B | CZK 2,130.26 | 0.01% up | 37% up | ||
| 16 | QiagenQGEN · Health Care | -0.07% | CZK 227.9B | CZK 1,103.45 | 0.07% down | 12% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | -0.17% | CZK 372.1B | CZK 3,676.55 | 0.17% down | 20% up | ||
| 18 | VaxcytePCVX · Health Care | -0.29% | CZK 208.1B | CZK 1,314.67 | 0.29% down | 22% up | ||
| 19 | ModernaMRNA · Health Care | -0.38% | CZK 1.85T | CZK 4,572.82 | 0.38% down | 755% up | ||
| 20 | Gilead SciencesGILD · Health Care | -0.56% | CZK 4.66T | CZK 3,757.78 | 0.56% down | 33% up | ||
| 21 | Revolution MedicinesRVMD · Health Care | -0.60% | CZK 776.3B | CZK 3,589.32 | 0.60% down | 131% up | ||
| 22 | ImmunityBioIBRX · Health Care | -0.93% | CZK 146.4B | CZK 137.65 | 0.93% down | 193% up | ||
| 23 | Twist BioscienceTWST · Health Care | -1.08% | CZK 167.7B | CZK 2,458.98 | 1.08% down | 340% up | ||
| 24 | AmgenAMGN · Health Care | -1.25% | CZK 5.43T | CZK 10,037.03 | 1.25% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.1960 CZK).
Questions and answers
Which biotech rank first by today's price change?
CRISPR Therapeutics (+4.74%), Scholar Rock Holding (+4.40%) and Repligen (+4.23%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 14:39 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of CZK 18.78T as of 18 Nov 2026, 14:39 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.